Article
Acute myeloid leukemia with monosomal karyotype at the far end of the unfavorable prognostic spectrum
31 Mar 2011
Abstract excerpt
[Introduction] The treatment of acute myeloid leukemia (AML) is among the most dose-intensive approaches in clinical oncology and involves variable therapeutic options with highly diverse consequences in terms of toxicities and anti-leukemic effects. One illustrative example is the choice between consolidation chemotherapy and stem cell transplantation in first remission and also the choice among highly diverse...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
